Stock 600299 BLUESTAR ADISSEO COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Financials Bluestar Adisseo Company

Equities

600299

CNE000001253

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 25/06/2024 BST 		5-day change 1st Jan Change
9.78 CNY +0.31% Intraday chart for Bluestar Adisseo Company 0.00% +22.25%
04-25 Bluestar Adisseo Company Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-25 Bluestar Adisseo Company announced that it expects to receive CNY 3 billion in funding CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 29,662 30,869 33,041 22,153 21,455 26,229 - -
Enterprise Value (EV) 1 29,662 29,026 31,861 23,338 22,310 24,801 27,373 26,336
P/E ratio - 23 x 22.4 x 18 x 400 x 28.8 x 23 x 17.9 x
Yield 1.41% 1.53% 1.44% 1.83% 0.75% 1.53% 1.36% 2.56%
Capitalization / Revenue 2.66 x 2.59 x 2.57 x 1.52 x 1.63 x 1.61 x 1.52 x 1.45 x
EV / Revenue 2.66 x 2.44 x 2.48 x 1.61 x 1.69 x 1.52 x 1.59 x 1.45 x
EV / EBITDA - 9.17 x 9.96 x 7.96 x 13.4 x 7.18 x 8.48 x 7.17 x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Price to Book 2.15 x 2.21 x 2.34 x 1.48 x 1.43 x 1.56 x 1.58 x 1.46 x
Nbr of stocks (in thousands) 2,681,901 2,681,901 2,681,901 2,681,901 2,681,901 2,681,901 - -
Reference price 2 11.06 11.51 12.32 8.260 8.000 9.780 9.780 9.780
Announcement Date 13/02/20 10/02/21 30/03/22 15/02/23 28/03/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 11,135 11,910 12,869 14,529 13,184 16,302 17,268 18,141
EBITDA 1 - 3,164 3,200 2,931 1,669 3,457 3,227 3,675
EBIT 1 1,589 2,046 2,082 1,503 68.37 2,108 1,642 2,048
Operating Margin 14.27% 17.18% 16.18% 10.34% 0.52% 12.93% 9.51% 11.29%
Earnings before Tax (EBT) 1 - 1,998 - 1,541 64.44 1,249 1,488 1,934
Net income 1 - 1,352 - 1,247 52.17 911 1,138 1,467
Net margin - 11.35% - 8.58% 0.4% 5.59% 6.59% 8.08%
EPS 2 - 0.5000 0.5500 0.4600 0.0200 0.3400 0.4248 0.5452
Free Cash Flow - - - - - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 0.1560 0.1760 0.1780 0.1510 0.0600 0.1500 0.1334 0.2501
Announcement Date 13/02/20 10/02/21 30/03/22 15/02/23 28/03/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2022 S2 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2023 S2 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2024 S2 2025 Q1 2025 Q2 2025 S1 2025 S2
Net sales 1 3,526 - - 3,605 3,729 7,334 3,152 3,176 3,286 3,569 6,855 3,496 3,970 7,844 3,800 3,416 7,860 - - 7,870 8,757
EBITDA 1 656.5 - - 590.3 - - - - - - - - 645 - 677.2 572.9 - - - - -
EBIT 1 402.1 - - 358.4 30 388.4 19.13 43.09 1,410 80.07 6.148 367 309.4 848.4 341.6 237.3 513 - - 550.8 549.7
Operating Margin 11.4% - - 9.94% 0.8% 5.3% 0.61% 1.36% 42.92% 2.24% 0.09% 10.5% 7.79% 10.82% 8.99% 6.95% 6.53% - - 7% 6.28%
Earnings before Tax (EBT) 1 - - - - - - 17.16 37.96 -73.19 82.51 - 359.4 295 - 346.9 177.1 - - - - -
Net income 1 - - - - - - 1.488 31.91 -67.81 86.57 - 276.9 221.3 - 260.2 124.9 - - - - -
Net margin - - - - - - 0.05% 1% -2.06% 2.43% - 7.92% 5.57% - 6.85% 3.66% - - - - -
EPS 2 0.0800 - - 0.1100 0.0300 - 0.000600 0.009400 -0.0200 0.0300 0.0100 0.1000 0.0825 0.2300 0.0970 0.0466 0.1300 - - 0.1400 0.1400
Dividend per Share 2 0.1780 - - - 0.1510 - - - - 0.0600 - - - - - - - 0.0376 0.0376 - -
Announcement Date 30/03/22 28/04/22 28/07/22 27/10/22 15/02/23 15/02/23 26/04/23 04/08/23 27/10/23 28/03/24 28/03/24 25/04/24 - - - - - - - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - 1,186 855 - 1,144 107
Net Cash position 1 - 1,843 1,180 - - 1,428 - -
Leverage (Debt/EBITDA) - - - 0.4045 x 0.5125 x - 0.3543 x 0.0292 x
Free Cash Flow - - - - - - - -
ROE (net income / shareholders' equity) 7.24% 9.97% 10.5% 8.71% 0.35% 9.18% 8.15% 10.1%
ROA (Net income/ Total Assets) 4.66% 6.48% - - 0.24% 3.6% 4.3% -
Assets 1 - 20,877 - - 21,432 25,307 26,473 -
Book Value Per Share 2 5.140 5.200 5.260 5.570 5.610 6.260 6.190 6.710
Cash Flow per Share 2 0.9500 1.010 0.9700 0.6400 1.030 0.7700 0.8700 -
Capex 1 1,237 1,310 2,313 1,531 1,447 1,279 1,765 1,279
Capex / Sales 11.11% 11% 17.98% 10.53% 10.97% 7.85% 10.22% 7.05%
Announcement Date 13/02/20 10/02/21 30/03/22 15/02/23 28/03/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Bluestar Adisseo Company

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
9.78 CNY
Average target price
10.01 CNY
Spread / Average Target
+2.35%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Veterinary Drugs

1st Jan change Capi.
BLUESTAR ADISSEO COMPANY Stock Bluestar Adisseo Company
+22.25% 3.61B
ZOETIS INC. Stock Zoetis Inc.
-13.41% 77.98B
ELANCO ANIMAL HEALTH INCORPORATED Stock Elanco Animal Health Incorporated
+20.60% 8.88B
VIMIAN GROUP AB Stock Vimian Group AB
+17.91% 1.67B
VETOQUINOL SA Stock Vetoquinol SA
-6.74% 1.2B
JINYU BIO-TECHNOLOGY CO., LTD. Stock Jinyu Bio-technology Co., Ltd.
-30.92% 1.14B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD. Stock China Animal Husbandry Industry Co., Ltd.
-34.32% 1.09B
WUHAN KEQIAN BIOLOGY CO.,LTD Stock Wuhan Keqian Biology Co.,Ltd
-25.17% 975M
SWEDENCARE AB Stock Swedencare AB
-3.46% 898M
TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD. Stock Tianjin Ringpu Bio-Technology Co.,Ltd.
-15.01% 887M
Veterinary Drugs
  1. Stock Market
  2. Equities
  3. 600299 Stock
  4. Financials Bluestar Adisseo Company